Nature’s Builders Biological Sintering Creates Sustainable Construction Materials

Concrete and brick are ubiquitous in construction, but their production is extraordinarily energy-intensive. Manufacturing Portland cement alone is responsible for approximately 8% of global carbon dioxide emissions. This patent describes a radically different approach: using bacteria and enzymes to precipitate calcium carbonate that binds aggregate materials into solid structures. The process occurs at ambient temperature and pressure without kilns or high-heat processing. The result is construction materials-bricks, pavers, panels-grown through biological sintering with a fraction of the embodied energy and carbon footprint of conventional manufacturing.

The Problem

Traditional brick and concrete production depends on heat. Concrete requires calcining limestone into lime, a process that demands tremendous energy and releases enormous quantities of carbon dioxide. Bricks are fired in kilns at temperatures exceeding 1000 degrees Celsius, again consuming massive amounts of fuel. These high-temperature processes are capital-intensive, geographically limited to locations with suitable infrastructure and fuel supplies, and fundamentally incompatible with decarbonization goals.

The construction industry is searching for alternatives. Hempcrete, recycled materials, and other solutions have emerged, but they often provide inferior structural properties or create new limitations. The ideal alternative would use abundant raw materials, require minimal processing energy, produce materials with equivalent structural properties, and generate minimal waste.

Microbial induced calcium carbonate precipitation (MICP) has been studied for years as a potential solution, but scaling it for construction materials manufacturing has proven challenging. The process requires careful control of microbial cultures, nutrient supplies, and environmental conditions. Getting biological precipitation to work reliably at production scale with affordable inputs and reasonable processing times has been the persistent technical barrier.

What This Invention Does

This patent describes a comprehensive system for manufacturing construction materials using biological sintering. The approach leverages two complementary groups of microorganisms: some that dissolve calcium carbonate (extracting usable calcium ions) and others that precipitate calcium carbonate (binding aggregate together).

The process begins with aggregate material (sand, crushed stone, or similar) pre-loaded with bacterial spores. These spores remain dormant in the dry material for extended periods, providing shelf life measured in years. When the spores are combined with an aqueous medium containing nutrients and the right environmental conditions, they germinate and multiply. The bacteria express enzymes that either dissolve existing calcium carbonate (Variovorax, Klebsiella, Pseudomonas, Bacillus, and others) or precipitate new calcium carbonate through biomineralization and others) or precipitate new calcium carbonate (Sporosarcina pasteurii, Bacillus sphaericus, and related species).

The dissolved calcium ions and free carbon from the first process become feedstock for the second process, where different bacteria precipitate new calcium carbonate that binds aggregate particles together. The entire transformation occurs at ambient temperature without kilns, furnaces, or high-temperature processing. Hardness can be controlled by adjusting initial components and pore size, allowing formulation for different structural requirements.

Key Features

Ambient-Temperature Processing. Unlike concrete and kiln-fired brick, biological sintering requires no high-temperature processing. Materials harden through enzymatic calcium carbonate precipitation at room temperature, eliminating the energy-intensive firing step.

Minimal Embodied Energy. The manufacturing process requires only mixing, moisture management, and time. No kilns, furnaces, or heat equipment are necessary. The result is construction material with dramatically lower embodied energy and carbon footprint.

Use of Abundant Minerals. The process can utilize calcium sources that are readily available globally-calcium carbonate deposits, limestone, even waste materials containing calcium. This eliminates dependence on specialized, energy-intensive lime manufacturing.

Structural Equivalence. The resulting calcium carbonate cement provides structural properties comparable to traditional masonry and concrete. Materials demonstrate hardness, durability, and load-bearing capacity suitable for construction applications.

Microbial Culture Stability. The innovation describes formulations where microorganisms remain viable for months or even years, simplifying logistics and manufacturing. Spore-containing aggregate can be stored dry, then activated when needed.

Flexible Manufacturing. The process can be scaled from small local operations to larger industrial production without requiring massive capital investment in heating infrastructure.

Who Is Behind It?

Biomason Inc., based in the United States, developed this technology with two inventors: J. Michael Dosier and Ginger K. Dosier. This represents a divisional patent application from an earlier patent (2020221335), indicating Biomason’s sustained development of biological sintering technology with progressively refined claims and embodiments.

Why It Matters

The construction industry is under intense pressure to reduce carbon emissions. Many nations have committed to net-zero carbon building standards. The concrete industry alone is responsible for 8% of global CO2 emissions-roughly 2.8 gigatons annually. A construction material that delivers equivalent or superior performance with a fraction of the carbon footprint represents a potential game-changer for achieving decarbonization goals.

The economic opportunity is correspondingly enormous. The global construction materials market exceeds 400 billion dollars annually. Even capturing a modest market share with lower-carbon alternatives represents billions in opportunity. For companies manufacturing bricks, pavers, and construction panels, a process that eliminates expensive energy costs while producing superior products is commercially transformative.

The technology is particularly valuable in developing regions where energy infrastructure is limited or expensive. Traditional brick and concrete manufacturing depends on access to cheap fuel and sophisticated infrastructure. Biological sintering requires only locally sourced aggregates, bacterial cultures, and water-all accessible globally.

The patent approach also addresses environmental concerns about traditional manufacturing. Using bacterial processes and natural calcium precipitation aligns with growing consumer and regulatory preferences for sustainable building materials. Developers and architects increasingly specify low-carbon materials, and this patent provides a credible pathway to products that meet those specifications.

The IPC classifications (A61L 27/02, C01F 11/18, C01B 25/32) indicate this is recognized as a significant innovation in biomedical materials and inorganic chemistry, reflecting the technical sophistication of the biological and chemical processes involved.

---

AU 2026201415 was published in the Australian Official Journal of Patents on 19 March 2026 and is open for public inspection. Patent applications represent inventions that are sought to be protected and do not necessarily reflect commercially available products.

Related Concepts

Biomineralization is the process by which living organisms produce minerals, often to harden or stiffen existing tissues. In construction, researchers have harnessed this principle through microbial-induced calcium carbonate precipitation, using bacteria such as Sporosarcina pasteurii to bind aggregate materials. This biological approach to sintering offers a compelling alternative to energy-intensive Portland cement manufacturing, with a dramatically lower carbon footprint and no requirement for kilns or high-temperature processing.